Details for New Drug Application (NDA): 020122

✉ Email this page to a colleague

NDA 020122 describes NIPENT, which is a drug marketed by Hospira Inc and is included in one NDA. It is available from one supplier. Additional details are available on the NIPENT profile page.

The generic ingredient in NIPENT is pentostatin. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pentostatin profile page.

Summary for 020122

Tradename:	NIPENT
Applicant:	Hospira Inc
Ingredient:	pentostatin
Patents:	0

Pharmacology for NDA: 020122

Mechanism of Action	Nucleic Acid Synthesis Inhibitors

Medical Subject Heading (MeSH) Categories for 020122

Adenosine Deaminase Inhibitors
Antineoplastic Agents

Suppliers and Packaging for NDA: 020122

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
NIPENT	pentostatin	INJECTABLE;INJECTION	020122	NDA	Hospira, Inc.	0409-0801	0409-0801-01	1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0801-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	10MG/VIAL
Approval Date:	Oct 11, 1991	TE:	AP	RLD:	Yes

Expired US Patents for NDA 020122

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Hospira Inc	NIPENT	pentostatin	INJECTABLE;INJECTION	020122-001	Oct 11, 1991	3,923,785	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.